Indications |
Oral Endometriosis Adult: 200-800 mg daily in 2 divided doses adjusted according to response, for 3-6 mth or if necessary, up to 9 mth. Oral Benign breast disorders Adult: Initially, 100-400 mg daily in 2 divided doses adjusted according to response and continued for 3-6 mth. Oral Gynaecomastia Adult: Male adolescents: Initially, 200 mg daily, may increase to 400 mg daily after 2 mth if no response occurs; adult men: Initial: 400 mg daily in up to 4 divided doses. Usual treatment duration: 6 mth. Child: Male adolescents: Initially, 200 mg daily increased to 400 mg after 2 mth if no response occurs. Treatment usually up to 6 months. Oral Hereditary angioedema Adult: Initially, 200 mg bid-tid reduced thereafter according to patient's response. Oral Preoperative thinning of the endometrium Adult: 400-800 mg daily, in up to 4 divided doses for 3-6 wk. Oral Menorrhagia Adult: 200 mg once daily. Review treatment 3 mth later. |
Contraindications |
Hypersensitivity, pregnancy, lactation, porphyria, thromboembolic disorders; undiagnosed genital bleeding, markedly impaired renal, cardiac or hepatic dysfunction. |
Warnings / Precautions |
Epilepsy, migraine; cardiac, hepatic, renal disorders. Severe hypertension, diabetes, polycythaemia, history of thrombosis; children. |
Adverse Reactions |
Oedema, wt gain, sweating, acne, hirsutism, flushing, oily skin or hair, deepening of the voice, clitoral hypertrophy, amenorrhoea, hepatic dysfunction, CNS or GI disturbances, benign intracranial hypertension, reduction in breast size, visual disturbances, elevated LFT values. Potentially Fatal: Thromboembolic events and fatal strokes have been reported. |
Drug Interactions |
Increased serum levels of ciclosporin, warfarin, carbamazepine and tacrolimus. Potentially Fatal: Increased incidence of insulin resistance in diabetic patients. See Below for More danazol Drug Interactions |
Food Interactions |
Increased conc with high fat meal. |
Mechanism of Actions |
Danazol suppresses the pituitary-ovarian axis by reducing the release of follicle-stimulating hormone and luteinizing hormone. This causes the regression and atrophy of endometrial tissue, decreases growth rate of abnormal breast tissue and reduces attacks in hereditary angioedema. Onset: Approximately 4 wk. Absorption: Absorbed from the GI tract (oral); absorption increases if taken with food. Metabolism: Hepatic (extensive); converted to 2-hydroxymethylethisterone. Excretion: Via the urine. |
Administration |
May be taken with or without food. (Take consistently either always w/ or always w/o meals.) |
ATC Classification |
G03XA01 - danazol ; Belongs to the class of antigonadotropins and similar agents. |
Available As |
|
Danazol
Post Review about Danazol Click here to cancel reply.
Danazol Containing Brands
Danazol is used in following diseases
Drug - Drug Interactions of Danazol
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.